Hemophilia Clinical Trials

A listing of Hemophilia medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
I am looking for
added new label for I am looking for
Advanced Filters
Found 92 clinical trials
Sonography and Haemophilia

device: The following questions will be answered: What is necessary for the organisational implementation of a patient-based ultrasound monitoring in patients with haemophilia

  • 08 Jun, 2022
  • 1 location
Osteoporosis and Haemophilia

The aim of this study is to evaluate the prevalence of osteoporosis in adult patients with haemophilia.

Factor VIII
antihemophilic factor
  • 03 Nov, 2021
  • 1 location
The Safety of Emicizumab SC Injection in Korean Hemophilia A Patients With/Without FVIII Inhibitors

To evaluate Safety and efficacy and pharmacokinetics, FVIII Inhibitor titers of Hemlibra subcutaneous injection (SC inj.) in Korean Hemophilia A patients with/without FVIII Inhibitors.

  • 01 Aug, 2021
  • 1 location
A Study of TAK-660 in Surgical Procedures for People With Hemophilia A.

This study is about a factor VIII medicine called Adynovate (TAK-660) used during surgery for people with hemophilia A who have low blood levels of factor VIII. The aims of this study are

  • 17 Oct, 2021
  • 1 location
Acquired Hemophilia A and Autoimmunity. Study of Lymphocyte Populations and Myeloid-Derived Suppressor Cells (IMMUNHEMAC)

Acquired hemophilia A is a rare condition of hemostasis secondary to the development of antibodies against factor VIII. This is a potentially serious pathology that can be life-threatening due

Accepts healthy volunteers
  • 21 Mar, 2022
  • 2 locations
Effects of Emicizumab vs. Factor VIII Prophylaxis on Joint and Bone Health in Severe Hemophilia A (EmiMSK)

The investigators propose to study longitudinal joint and bone density changes in patients with severe Hemophilia A. Per current standard of care, most patients are on prophylactic FVIII

  • 16 May, 2022
  • 1 location
A Study of Standard and Individualized Prophylactic Treatment With Advate in Men and Boys With Severe Hemophilia A

The main aim of this study is to learn about changes in the lowest blood levels of Factor VIII in men and boys when upgraded from standard prophylaxis with Advate to individualized prophylaxis with Advate. No study medicines will be provided to participants in this study. The study sponsor will …

  • 07 Oct, 2021
  • 10 locations
A Study in Children, Teenagers and Adults With Severe Hemophilia A Who Switched From Other Factor VIII Treatments to Adynovate

The main aims of the study are to assess the safety profile of Adynovate as well as how well people respond to the preventive treatment with Adynovate. This study is about reviewing and collecting data of the participants before and after the switch to Adynovate that are already available. No …

  • 25 May, 2022
  • 1 location
A Survey on the Success of Inhibitor Elimination Using Individualized Concentrate Selection and Controlled ITI

This research program is initiated to evaluate and document data on the success of ITI in 300 haemophilia A patients with newly developed or already existing FVIII-inhibitors (also patients who

thrombin generation test
antihemophilic factor
  • 16 Sep, 2021
  • 1 location
ADYNOVATE Drug Use-Results Survey

deficiency (hereinafter hemophilia A) Safety and efficacy for hemophilia A patients who received routine prophylactic therapy and on-demand therapy

factor viii inhibitor
antihemophilic factor
coagulation factor
  • 10 Mar, 2022
  • 49 locations